ObsEva SA (OBSV): Price and Financial Metrics
GET POWR RATINGS... FREE!
OBSV Stock Price Chart Interactive Chart >
OBSV Price/Volume Stats
| Current price | $0.21 | 52-week high | $2.14 |
| Prev. close | $0.19 | 52-week low | $0.13 |
| Day low | $0.19 | Volume | 1,393,700 |
| Day high | $0.21 | Avg. volume | 549,594 |
| 50-day MA | $0.17 | Dividend yield | N/A |
| 200-day MA | $0.73 | Market Cap | 16.16M |
ObsEva SA (OBSV) Company Bio
ObsEva SA, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women between the ages of 15 and 49 suffering from reproductive health and pregnancy. The company intends to develop treatments for treating endometriosis, uterine fibroids, and preterm labor. The company was founded in 2012 and is based in Switzerland.
Latest OBSV News From Around the Web
Below are the latest news stories about OBSEVA SA that investors may wish to consider to help them evaluate OBSV as an investment opportunity.
How should investors view ObsEva SA (OBSV)?In Monday’s session, ObsEva SA (NASDAQ:OBSV) marked $0.19 per share, up from $0.18 in the previous session. While ObsEva SA has overperformed by 1.37%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, OBSV fell by -90.75%, with highs and lows ranging from $2.14 to $0.13, whereas […] |
Bustling Stock: Harpoon Therapeutics, Inc. (NASDAQ:HARP -2.16%), ObsEva SA (NASDAQ:OBSV 8.07%)Harpoon Therapeutics, Inc. (NASDAQ:HARP) with the stream of -2.16% also noticed, India ObsEva SA (NASDAQ:OBSV) encountered a rapid change of 8.07% in the last hour of Tuesday’s trading session. Harpoon … The post Bustling Stock: Harpoon Therapeutics, Inc. (NASDAQ:HARP -2.16%), ObsEva SA (NASDAQ:OBSV 8.07%) appeared first on Stocks Equity . |
Can you now get a good deal on ObsEva SA’s shares?ObsEva SA (NASDAQ:OBSV) marked $0.14 per share on Tuesday, down from a previous closing price of $0.15. While ObsEva SA has underperformed by -4.60%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, OBSV fell by -93.44%, with highs and lows ranging from $2.21 to $0.13, whereas […] |
ObsEva SA: ObsEva Announces Dismissal of Moratorium ProceedingsAd hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland - December 19, 2022 - ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commer… |
ObsEva Announces Dismissal of Moratorium ProceedingsAd hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – December 19, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women’s health, today announced that the competent court in Geneva, Switzerland has granted the Company’s request to withdraw its moratorium considering that the Company is no longer over-indebted. The Company resolved its over-indebtedness due to the previously announced |
OBSV Price Returns
| 1-mo | 48.94% |
| 3-mo | 11.82% |
| 6-mo | -18.29% |
| 1-year | -86.45% |
| 3-year | -94.40% |
| 5-year | -98.06% |
| YTD | 44.83% |
| 2022 | -92.71% |
| 2021 | -4.33% |
| 2020 | -45.55% |
| 2019 | -69.83% |
| 2018 | 29.71% |
Loading social stream, please wait...